Groups working on public health inequalities in China are rightly concerned that, since prices of patented drugs are typically much higher than for generic versions, any price inflation will hurt the poorest hardest.
Groups working on public health inequalities in China are rightly concerned that, since prices of patented drugs are typically much higher than for generic versions, any price inflation will hurt the poorest hardest.